Drug target · CHRNA3
alpha3beta4 nAChR
Neuronal nicotinic acetylcholine receptor alpha3beta4 subtype (CHRNA3/CHRNB4 heteropentamer), ganglionic
1 compound in the CNS pipeline acts on alpha3beta4 nAChR.
Compounds targeting alpha3beta4 nAChR
| Compound | Action | Affinity | Lead program | Developer |
|---|---|---|---|---|
| RopanicantSmall molecule | Antagonist | — | Phase 2Major depressive disorder | Suven Life Sciences Limited |